Briefs: Eugia Steriles and Shelter Pharma
Drug Approval

Briefs: Eugia Steriles and Shelter Pharma

Eugia Steriles receives EIR from USFDA for new injectable facility

  • By IPP Bureau | September 18, 2024

Eugia Steriles receives EIR from USFDA for new injectable facility

The United States Food and Drug Administration (US FDA) had conducted a Pre-Approval Inspection (PAI) of the new injectable facility of Eugia Steriles Private Limited (a 100% subsidiary of Eugia Pharma Specialities Limited and a stepdown subsidiary of the Company), situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, from March 28, 2024 to April 05, 2024. The Unit has now received the Establishment Inspection Report (EIR) and the inspection is closed.

Shelter Pharma ecures order from Al-Saqr Agro

Shelter Pharma Limited has secured a noteworthy order from Al-Saqr Agro For Agricultural And Veterinary Entries of Super Vltamas (Feed Supplements), Total Order worth $17,700.

Upcoming E-conference

Other Related stories

Startup

Digitization